title: Neuraminidase antibodies and H5N1: geographic-dependent influenza epidemiology could determine cross-protection against emerging strains.
authors.forename: Jesus F
authors.initials: JF
authors.lastname: Bermejo-Martin
authors.forename: David J
authors.initials: DJ
authors.lastname: Kelvin
authors.forename: Yi
authors.initials: Y
authors.lastname: Guan
authors.forename: Honglin
authors.initials: H
authors.lastname: Chen
authors.forename: Pilar
authors.initials: P
authors.lastname: Perez-Breña
authors.forename: Inmaculada
authors.initials: I
authors.lastname: Casas
authors.forename: Eduardo
authors.initials: E
authors.lastname: Arranz
authors.forename: Raul O
authors.initials: RO
authors.lastname: de Lejarazu
mesh_terms: D000818:Animals; D000914:Antibodies, Viral / Q000276:immunology*; D004196:Disease Outbreaks / Q000517:prevention & control; D006801:Humans; D053124:Influenza A Virus, H5N1 Subtype / Q000276:immunology*; D007252:Influenza Vaccines / Q000276:immunology / Q000627:therapeutic use; D007251:Influenza, Human / Q000453:epidemiology / Q000276:immunology* / Q000517:prevention & control; D051379:Mice; D009439:Neuraminidase / Q000276:immunology*; D009976:Orthomyxoviridae Infections / Q000453:epidemiology / Q000276:immunology* / Q000517:prevention & control
chemical_list: D000914:Antibodies, Viral; D007252:Influenza Vaccines; D009439:Neuraminidase